Shatavari for Menopause

N/A

Recruiting

Research Sponsored by SF Research Institute, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Menopausal women aged 45 to 65 years with intact uterus and ovaries

Be between 18 and 65 years old

Must not have

Participants who are on hormone replacement therapy (HRT) for more than 3 months

Participants who taking medication that affect bone metabolism, including glucocorticoid, anticonvulsant, and methotrexate

Timeline

Screening 3 weeks

Treatment Varies

Follow Up pss assessment will be done at visit 1, screening visit/ enrolment visit/ baseline visit, (day 1), visit 2 (week 4), visit 3 end of study visit, (week 8).

Summary

"This trial is studying the effects of Shatavari on menopausal symptoms in women. Participants will be divided into three groups and will take either Shatavari, Shatavari +

Who is the study for?

This trial is for women experiencing menopause with symptoms like hot flashes and depression. Participants should take a capsule daily after breakfast for 8 weeks, without changing their diet or exercise routines.

What is being tested?

The study tests the effectiveness of Shatavari alone or combined with Ashwagandha against a placebo in reducing menopausal symptoms. Women are randomly assigned to one of three groups in this double-blind study.

What are the potential side effects?

Potential side effects were not provided, but typically herbal supplements like Shatavari and Ashwagandha may cause digestive upset, allergic reactions, or interact with other medications.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a woman aged 45-65, not undergoing menopause, with my uterus and ovaries intact.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have been on hormone replacement therapy for over 3 months.

Select...

I am taking medication that affects bone health, like steroids or methotrexate.

Select...

I have had both of my ovaries surgically removed.

Select...

I cannot attend follow-up visits.

Select...

I currently have active health issues that need medical attention.

Select...

I have a history of breast or cervical cancer.

Select...

I understand the details and risks of the study.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ pss assessment will be done at visit 1, screening visit/ enrolment visit/ baseline visit, (day 1), visit 2 (week 4), visit 3 end of study visit, (week 8).

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~pss assessment will be done at visit 1, screening visit/ enrolment visit/ baseline visit, (day 1), visit 2 (week 4), visit 3 end of study visit, (week 8).

This trial's timeline: 3 weeks for screening, Varies for treatment, and pss assessment will be done at visit 1, screening visit/ enrolment visit/ baseline visit, (day 1), visit 2 (week 4), visit 3 end of study visit, (week 8). for reporting.